Clinical Trial Update: Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese [NA]

View source ↗

Summary

A terminated clinical trial evaluated the safety and efficacy of the EndoBarrier device in obese patients with type 2 diabetes; results were posted in December …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• EndoBarrier (duodenal-jejunal bypass liner)

Snippet

Sponsor: Morphic Medical Inc. | Conditions: Type 2 Diabetes, Obesity | NA | Status: TERMINATED | Results posted: 2016-12-02